CSF2 and infection: This might be an effect of GM-CSF and could contribute to minimizing risk for infections [24,25] Moreover, leukemic blasts in PB remained below the (immunological) detection limit over the whole phase of treatment in patient 1482, although 70% BM blasts were detectable before start of Kit M treatment.